XML 64 R48.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Basis of Presentation and Our Divisions (COVID-19) (Details) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 25, 2021 | Dec. 26, 2020
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | $ (32) | $ 56
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | (23) | 59
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | (1) | 72
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 128 | 350
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 70 | 161
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 6 | 76
Charges Related to Novel Coronavirus (COVID-19) | 148 | 774
Reserve for Product Returns Novel Coronavirus (COVID-19) Impact |  | 20
Social Welfare Credit Novel Coronavirus (COVID-19) Impact |  | 11
Frito Lay North America [Member] |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (8) | 17
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 0 | 8
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 35 | 145
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 27 | 59
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 2 | 0
Charges Related to Novel Coronavirus (COVID-19) | 56 | 229
Quaker Foods North America [Member] |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 2
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 0 | 0
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 2 | 9
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 1 | 3
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 0 | 1
Charges Related to Novel Coronavirus (COVID-19) | 2 | 15
PepsiCo Beverages North America [Member] |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (19) | 29
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | (21) | 56
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 0 | 28
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 31 | 115
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 14 | 50
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | (16) | 26
Charges Related to Novel Coronavirus (COVID-19) | (11) | 304
Africa, Middle East and South Asia [Member] |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 2
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | (2) | 3
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 1 | 9
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 3 | 7
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 6 | 12
Charges Related to Novel Coronavirus (COVID-19) | 7 | 33
Asia Pacific, Australia and New Zealand, and China Region [Member] |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | 0 | 0
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 0 | 3
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 2 | (7)
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 2 | 2
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 5 | 5
Charges Related to Novel Coronavirus (COVID-19) | 9 | 3
Latin America |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | 0 | 1
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 1 | 19
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 44 | 56
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 15 | 18
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 4 | 8
Charges Related to Novel Coronavirus (COVID-19) | 64 | 102
Europe |  |
Segment Reporting Information [Line Items] |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (3) | 5
Prepaid Incentives Novel Coronavirus (COVID-19) Impact | (2) | 3
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact | 0 | 11
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 13 | 23
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 8 | 22
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 5 | 24
Charges Related to Novel Coronavirus (COVID-19) | $ 21 | $ 88

X
- Definition Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_AccountsReceivableCreditLossExpensereversalNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Charges Related to Novel Coronavirus (COVID-19) + References No definition available. + Details
Name: | pep_ChargesRelatedtoNovelCoronavirusCOVID19
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Charges Related to Novel Coronavirus (COVID-19) Impact - Other + References No definition available. + Details
Name: | pep_ChargesRelatedtoNovelCoronavirusCOVID19ImpactOther
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Employee Compensation Expense Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_EmployeeCompensationExpenseNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Employee Compensation Costs Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_EmployeeProtectionCostsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_InventoryWritedownandProductReturnsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Prepaid Incentives Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_PrepaidIncentivesNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Reserve for Product Returns Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_ReserveforProductReturnsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Social Welfare Credit Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_SocialWelfareCreditNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_FritoLayNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_QuakerFoodsNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_PepsiCoBeveragesNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_AfricaMiddleEastandSouthAsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_AsiaPacificAustraliaandNewZealandandChinaRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_LatinAmericaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_EuropeSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |